AstraZeneca CEO lands mega-deal, defends vaccine efficiency
Shiv Shankar Sahu Monday 14th of December 2020 12:34 PM
(0) (0)
AstraZeneca announced Saturday it plans to buy rare-disease specialist Alexion Pharmaceuticals Inc. In an interview during his confinement, CEO Pascal Soriot downplayed the criticisms against their vaccine, blaming “armchair quarterbacks” who have blown matters out of proportion..
Read more: HINDUSTANTIMES.COM
Leave Your Response